In today’s session Health Care SPDR (ETF) (XLV) registered an unusually high (10,164) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the November, 2016 call, expecting serious XLV increase. With 10,164 contracts traded and 117334 open interest for the Nov, 16 contract, it seems this is a quite bullish bet. The option with symbol: XLV161118C00072000 closed last at: $1.57 or 423.3% up. Health Care SPDR (ETF) (NYSEARCA:XLV) has risen 3.98% since April 11, 2016 and is uptrending. It has underperformed by 2.16% the S&P500.
Health Care Select Sector SPDR Fund seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The ETF has a market cap of $12.07 billion. The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor’s 500 Composite Stock Index (S&P 500). It has a 5.49 P/E ratio. The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology.
XLV Company Profile
Health Care Select Sector SPDR Fund (the Fund) seeks to provide investment results that correspond to the price and yield performance of the Health Care Select Sector of the S&P 500 Index (the Index). The Index includes companies whose primary business may include healthcare equipment and supplies, healthcare services, biotechnology and pharmaceuticals.
More recent Health Care SPDR (ETF) (NYSEARCA:XLV) news were published by: Seekingalpha.com which released: “Valuation Dashboard: Healthcare – Update” on November 09, 2016. Also Etfdailynews.com published the news titled: “Traders Are Betting Heavily on More Healthcare Stock Declines” on October 27, 2016. Etfdailynews.com‘s news article titled: “Are Health Care ETFs a Buy Heading Into Earnings Season?” with publication date: October 24, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.